Hevert Detox Intestinum

Eichhornia Crassipes Whole, Okoubaka Aubrevillei Bark, Quassia Amara Wood, And Taraxacum Officinale


Hevert Arzneimittel Gmbh & Co Kg
Human Otc Drug
NDC 54532-0031
Hevert Detox Intestinum also known as Eichhornia Crassipes Whole, Okoubaka Aubrevillei Bark, Quassia Amara Wood, And Taraxacum Officinale is a human otc drug labeled by 'Hevert Arzneimittel Gmbh & Co Kg'. National Drug Code (NDC) number for Hevert Detox Intestinum is 54532-0031. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Hevert Detox Intestinum drug includes Eichhornia Crassipes Whole - 1 [hp_X]/50mL Okoubaka Aubrevillei Bark - 2 [hp_X]/50mL Quassia Amara Wood - 1 [hp_X]/50mL Taraxacum Officinale - 1 [hp_X]/50mL . The currest status of Hevert Detox Intestinum drug is Active.

Drug Information:

Drug NDC: 54532-0031
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Hevert Detox Intestinum
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Eichhornia Crassipes Whole, Okoubaka Aubrevillei Bark, Quassia Amara Wood, And Taraxacum Officinale
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Hevert Arzneimittel Gmbh & Co Kg
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:EICHHORNIA CRASSIPES WHOLE - 1 [hp_X]/50mL
OKOUBAKA AUBREVILLEI BARK - 2 [hp_X]/50mL
QUASSIA AMARA WOOD - 1 [hp_X]/50mL
TARAXACUM OFFICINALE - 1 [hp_X]/50mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 15 Jun, 2016
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 24 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Hevert Arzneimittel GmbH & Co KG
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:216V7S21BH
MK2074187Z
S5249Q85HW
39981FM375
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
54532-0031-51 BOTTLE in 1 CARTON (54532-0031-5) / 50 mL in 1 BOTTLE15 Jun, 2016N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Active ingredients purpose "x" indicates a homeopathic dilution. for more information visit: www.hevertusa.com eichhornia 1x bloating constipation okoubaka 2x nausea quassia amara tm bloating taraxacum officinale 1x bloating abdominal fullness

Product Elements:

Hevert detox intestinum eichhornia crassipes whole, okoubaka aubrevillei bark, quassia amara wood, and taraxacum officinale eichhornia crassipes whole eichhornia crassipes whole okoubaka aubrevillei bark okoubaka aubrevillei bark quassia amara wood quassia amara wood taraxacum officinale taraxacum officinale alcohol water

Indications and Usage:

Uses for temporary relief of symptoms of upset stomach and indigestion, such as: bloating abdominal fullness nausea constipation claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Warnings:

Warnings for oral use only. stop use and ask a doctor if symptoms persist for more than 7 days, worsen or new symptoms occur. if pregnant or breast-feeding, ask a health professional before use. keep out of reach of children. in case of overdose, get medical help or contact a poison control center right away.

Dosage and Administration:

Directions adults and children over 12 years of age: take 20 drops in water 3 times daily. consult a physician for use in children under 12 years of age.

Stop Use:

Stop use and ask a doctor if symptoms persist for more than 7 days, worsen or new symptoms occur.

Package Label Principal Display Panel:

Principal display panel - 50 ml bottle carton ndc 54532-0031-5 hevert ® detox intestinum homeopathic medicine relieves symptoms of upset stomach and indigestion 1.7 fl oz (50 ml) 60 % alcohol v/v oral drops made in germany hevert principal display panel - 50 ml bottle carton

Further Questions:

Questions? 1-855-387-6466


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.